Pyoderma gangrenosum recurred in more than a third of patients after complete healing in a study, and cumulative recurrence risk reached 41% at 5 years. Recurrence occurred in 41 (35%) of 116 ...

Please provide your email address to receive an email when new articles are posted on . A minimal important difference of 7-day pain scores was a 2-point improvement on an 11-point scale. A 2-point ...

US Food and Drug Administration awards Fast Track designation for the treatment of ulcerative pyoderma gangrenosum Fast track follows recently reported orphan drug designation by both US FDA and EMA ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Ulcerative pyoderma gangrenosum is a rare disease with ...

Vilobelimab is a first-in-class anti-human complement factor C5a monoclonal antibody. The Food and Drug Administration (FDA) has granted Fast Track designation to vilobelimab for the treatment of ...

An 83-year-old woman presented with a non-healing ulcer on her left lower extremity. According to the woman’s caregiver, she had had the ulcer for more than 20 years. She reported no history of ...